Literature DB >> 1093654

Synergy of trimethoprim-sulfamethoxazole.

S R Bushby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1093654      PMCID: PMC1956440     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  20 in total

1.  Trimethoprim R factors in enterobacteria from clinical specimens.

Authors:  R S Jobanputra; N Datta
Journal:  J Med Microbiol       Date:  1974-05       Impact factor: 2.472

2.  Nature of trimethoprim-induced death in Escherichia coli.

Authors:  P Angehrn; R Then
Journal:  Arzneimittelforschung       Date:  1973-03

3.  Characteristics of some co-trimoxazole-resistant Enterobacteriaceae from infected patients.

Authors:  J Barker; D Healing; J G Hutchison
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

Review 4.  Trimethoprim-sulfamethoxazole: in vitro microbiological aspects.

Authors:  S R Bushby
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

5.  [Extra-chromosomal, transmissible antibiotic resistance in human pathogens].

Authors:  G Lebek
Journal:  Hippokrates       Date:  1972-03

6.  Antimicrobial sensitivity patterns as a guide to the domiciliary treatment of urinary tract infections.

Authors:  I J Hunter
Journal:  Med J Aust       Date:  1972-02-26       Impact factor: 7.738

Review 7.  Folate antagonists as antibacterial and antiprotozoal agents.

Authors:  G H Hitchings
Journal:  Ann N Y Acad Sci       Date:  1971-11-30       Impact factor: 5.691

8.  Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media.

Authors:  A E Koch; J J Burchall
Journal:  Appl Microbiol       Date:  1971-11

9.  Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model of urinary infection.

Authors:  J D Anderson; R W Lacey; E L Lewis; M A Sellin
Journal:  J Clin Pathol       Date:  1974-08       Impact factor: 3.411

10.  Resistance of Staphylococcus aureus to sulphamethoxazole and trimethoprim.

Authors:  L S Nakhla
Journal:  J Clin Pathol       Date:  1972-08       Impact factor: 3.411

View more
  15 in total

1.  Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus.

Authors:  D J Livorsi; E Crispell; S W Satola; E M Burd; R Jerris; Y F Wang; M M Farley
Journal:  Antimicrob Agents Chemother       Date:  2012-05-14       Impact factor: 5.191

2.  Anti-folates potentiate bactericidal effects of other antimicrobial agents.

Authors:  Kun Li; Xu-de Wang; Shan-Shan Yang; Jing Gu; Jiao-Yu Deng; Xian-En Zhang
Journal:  J Antibiot (Tokyo)       Date:  2017-01-11       Impact factor: 2.649

3.  The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis.

Authors:  Catherine Vilchèze; William R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2012-07-23       Impact factor: 5.191

4.  Structure of aminodeoxychorismate synthase from Stenotrophomonas maltophilia.

Authors:  Asim K Bera; Vesna Atanasova; Anjali Dhanda; Jane E Ladner; James F Parsons
Journal:  Biochemistry       Date:  2012-12-11       Impact factor: 3.162

5.  Small-molecule inhibitors of Staphylococcus aureus RnpA-mediated RNA turnover and tRNA processing.

Authors:  Tess M Eidem; Nicole Lounsbury; John F Emery; Jeffrey Bulger; Andrew Smith; Magid Abou-Gharbia; Wayne Childers; Paul M Dunman
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

6.  Characterization of Stenotrophomonas maltophilia phage AXL1 as a member of the genus Pamexvirus encoding resistance to trimethoprim-sulfamethoxazole.

Authors:  Jaclyn G McCutcheon; Andrea Lin; Jonathan J Dennis
Journal:  Sci Rep       Date:  2022-06-18       Impact factor: 4.996

Review 7.  Cotrimoxazole and neonatal kernicterus: a review.

Authors:  Baskaran Thyagarajan; Sharad S Deshpande
Journal:  Drug Chem Toxicol       Date:  2013-10-07       Impact factor: 3.356

8.  Design and Synthesis of a Focused Library of Diamino Triazines as Potential Mycobacterium tuberculosis DHFR Inhibitors.

Authors:  Arundhati C Lele; Archana Raju; Mihir P Khambete; M K Ray; M G R Rajan; Manisha A Arkile; Nandadeep J Jadhav; Dhiman Sarkar; Mariam S Degani
Journal:  ACS Med Chem Lett       Date:  2015-10-17       Impact factor: 4.345

9.  Factors that cause trimethoprim resistance in Streptococcus pyogenes.

Authors:  René Bergmann; Mark van der Linden; Gursharan S Chhatwal; D Patric Nitsche-Schmitz
Journal:  Antimicrob Agents Chemother       Date:  2014-02-03       Impact factor: 5.191

10.  Pharmacokinetic study of the new sulfamethopyrazine-trimethoprim combination (kelfiprim) in renal insufficiency.

Authors:  A Cantaluppi; G Graziani; C Ponticelli; S Grasso; G Meinardi; F Piaia; V Tamassia
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.